Patients with AF taking aspirin with anticoagulant at increased bleeding risk without clear benefit

Many patients with atrial fibrillation (AF) are receiving aspirin (A) in addition to an oral anticoagulant (OAC), despite the fact that 40 per cent of the patients in this study had no indication for aspirin (eg no known atherosclerotic disease). Concomitant use of aspirin increased the risk of bleeding over OAC alone without any clear benefit regarding cardiovascular events.

Patients with AF taking aspirin with anticoagulant at increased bleeding risk without clear benefit

Add yours ↓
Web design and marketing agency Leamington Spa